Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000424484

Medchemexpress LLC Clovibactin TFA | 97.1% | 903.08 (free base) | 500 UG
SDP

Catalog No. 5000424484
Encompass_Preferred

Clovibactin TFA is the TFA salt form of Clovibactin. It acts as an antibiotic against drug-resistant bacterial pathogens without detectable resistance, functioning by inhibiting cell wall synthesis, specifically targeting pyrophosphate of peptidoglycan precursors.

  • Inhibits cell wall synthesis.
  • Targets pyrophosphate of peptidoglycan precursors.
  • Effective against Staphylococcus strains with MICs of 0.125-2 μg/mL.
  • For research use only.
  • Molecular weight: 903.08 (free base).
  • Formula: C43H70N10O11.xC2HF3O2.
  • Appearance: Solid, white to off-white.
  • Solubility: DMSO: 100 mg/mL (Need ultrasonic).

Catalog No. 50-004-24484 Supplier Medchemexpress LLC Supplier No. HYP10027A500UG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Clovibactin TFA is the TFA salt form of Clovibactin. It acts as an antibiotic against drug-resistant bacterial pathogens without detectable resistance, functioning by inhibiting cell wall synthesis, specifically targeting pyrophosphate of peptidoglycan precursors.

  • Inhibits cell wall synthesis.
  • Targets pyrophosphate of peptidoglycan precursors.
  • Effective against Staphylococcus strains with MICs of 0.125-2 μg/mL.
  • For research use only.
  • Molecular weight: 903.08 (free base).
  • Formula: C43H70N10O11.xC2HF3O2.
  • Appearance: Solid, white to off-white.
  • Solubility: DMSO: 100 mg/mL (Need ultrasonic).

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.